Jeffrey Quinones

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The University of Western Australia

Mahidol University

Ben-Gurion University of the Negev

Clinical Research Puerto Rico

Jeffrey Quinones is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in vaccine safety, pediatric immunization, and infant immunization.

Publications per year

2022–2023

Publications

A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)

Robert Lupinacci, Richard Rupp, Orasri Wittawatmongkol et al. · Vaccine · 2023 · 43 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)

Androniki Bili, Scott Dobson, Jeffrey Quinones et al. · Vaccine · 2022 · 18 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

1–2 of 2